RecruitingNot ApplicableNCT06728592

Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group


Sponsor

Chinese University of Hong Kong

Enrollment

100 participants

Start Date

Dec 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Background Reperfusion therapies, i.e., intravenous thrombolysis (IVT) and/or endovascular thrombectomy (EVT), are most effective treatments in the management of acute ischemic stroke (AIS) patients. The benefits of reperfusion therapies, however, may be reduced by treatment delays due to tests and examinations and logistic issues. Emergency Stroke Unit (ESU), a new concept of stroke unit locating at the Accident and Emergency Department (AED), equipped with a mobile, low-field MR imaging (lfMRI) scanner for fast diagnosis of ischemic stroke, differentiation of intracranial hemorrhage and identification of large vessel occlusion (LVO), is being tested in Mainland China. It may shorten the door-to-needle time (DNT) for IVT and door-to-groin puncture time (DPT) for EVT, which may hance associate with improved functional outcomes of AIS patients. This is a prospective, single-center, open-label, non-randomized, single-arm study aims to evaluate the safety and efficacy of the ESU workflow using lfMRI in shortening the DNT/DPT and improving functional outcomes in AIS patients, who are potentially eligible for IVT and/or EVT and can be treated within 6 hours after onset, compared with standard practice in Hong Kong; to reveal the changes in the ischemic lesions over a few days after IVT/EVT in these patients, with serial follow-up lfMRI exams.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria5

  • Age ≥18 years;
  • Diagnosed as ischemic stroke;
  • Potentially eligible for IVT and/or EVT and can be treated within 6 hours of symptom onset (time of symptom onset is defined as the last known normal time);
  • Presenting to AED during working hours (8AM to 6PM, weekdays);
  • Written informed consent from patients or representatives, who understand Cantonese, to participate in this study.

Exclusion Criteria7

  • Patients with unstable vital signs who need urgent medical interventions/care;
  • Confirmed contraindications for IVT or EVT by initial assessment (e.g., unstable vital signs, history of severe head trauma within 3 months, known bleeding tendency), before starting brain imaging exams;
  • Claustrophobia or other conditions that are contraindicated for MRI;
  • Patients with pacemakers, brain stimulators or insulin pumps;
  • Patients with medical or other conditions that prevent cooperation with the procedures;
  • Pregnant or breastfeeding women;
  • Participation in other clinical trials within 3 months before screening.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPortable Magnetic Resonance Imaging

0.23T Low-field Magnetic Resonance Imaging


Locations(1)

Chinese University of Hong Kong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06728592


Related Trials